Discover the latest in health: evidence‑based wellness tips, medical breakthroughs, nutrition guidance, fitness insights, and expert advice for a healthier, happier life.
A new study is suggesting a surprising benefit to the shingles vaccine: it may slow down the biological aging process. Researchers at the University of Southern California (USC) have found evidence that individuals who receive the vaccine exhibit markers of slower aging compared to those who haven’t, adding another layer to the vaccine’s already established protective benefits against the painful reactivation of the varicella-zoster virus.
The findings, published in February 2026, stem from an analysis of data from nearly 4,000 seniors. This research adds to a growing body of evidence suggesting that vaccines can have effects beyond simply preventing infectious diseases, potentially influencing the fundamental processes of aging. The study focused on identifying whether a shingles vaccine could create differences in biological aging.
The research team, led by Jung Ki Kim and Eileen Crimmins, examined seven key areas associated with biological aging: inflammation, innate immunity, adaptive immunity, cardiovascular health, neurodegeneration, epigenetic alterations, and transcriptomic changes. These areas were assessed using data from the Health and Retirement Study, a long-term study with a nationally representative sample of older adults. The study included 3,884 participants aged 70 and older, with available data on vaccination status, blood samples, and health information, according to News.de.
How the Vaccine Impacts Aging Markers
The study revealed that individuals who had been vaccinated against shingles demonstrated improvements in several of these aging markers. Specifically, the vaccinated group showed reduced inflammation, a key driver of age-related decline. Chronic, low-grade inflammation is known to accelerate the aging process and contribute to a range of health problems. The vaccine also appeared to positively influence immune function and cardiovascular health. Apotheke Adhoc reports that the strongest effects were observed within the first three years after vaccination.
The varicella-zoster virus, which causes chickenpox, remains dormant in the body after initial infection. As the immune system weakens with age, stress, or illness, the virus can reactivate, leading to shingles – a painful rash. Vaccination against shingles is recommended for individuals aged 60 and older, and even earlier for those with compromised immune systems. The Standing Committee on Vaccination (STIKO) in Germany recommends vaccination against shingles, and has recommended varicella vaccination for children since 2004.
Understanding Biological vs. Chronological Age
It’s important to distinguish between chronological age – the number of years a person has lived – and biological age, which reflects the overall health and function of the body’s systems. Biological age can be influenced by a variety of factors, including genetics, lifestyle, and environmental exposures. The USC study suggests that the shingles vaccine may be able to favorably alter biological age, potentially reducing the risk of age-related diseases.
Researchers believe the vaccine’s impact on inflammation is a key mechanism driving these anti-aging effects. By boosting the immune system’s response to the virus, the vaccine may also help to regulate inflammation and improve overall immune function. Focus Online highlights that the study analyzed seven central aspects of biological aging, including inflammation processes, innate immunity, and neurodegeneration.
Implications and Future Research
Even as these findings are promising, researchers emphasize that this is an observational study and does not prove a causal relationship between the shingles vaccine and slower aging. Further research is needed to confirm these results and to understand the underlying mechanisms involved. However, the study provides a compelling rationale for considering shingles vaccination as a potential strategy for promoting healthy aging.
The implications of this research extend beyond shingles prevention. If further studies confirm these findings, it could open up new avenues for developing vaccines and other interventions aimed at slowing down the aging process and improving overall healthspan – the period of life spent in good health. The study suggests that shingles vaccinations may influence important areas of the aging process, according to T-Online.
Disclaimer: This article provides informational content and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on these findings? Share your comments below, and please share this article with anyone who might uncover it helpful.